For a long time, the likelihood of surviving pancreatic cancer has been extremely low.

For a long time, the likelihood of surviving pancreatic cancer has been extremely low.

The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer — but it doesn't cure the disease and only works if the cancer is…